FY2019 Earnings Forecast for DENTSPLY SIRONA Inc Issued By William Blair (NASDAQ:XRAY)

DENTSPLY SIRONA Inc (NASDAQ:XRAY) – William Blair boosted their FY2019 earnings per share estimates for shares of DENTSPLY SIRONA in a report released on Monday, May 6th, Zacks Investment Research reports. William Blair analyst J. Kreger now anticipates that the medical instruments supplier will earn $2.34 per share for the year, up from their previous estimate of $2.32. William Blair currently has a “Outperform” rating and a $56.71 target price on the stock. William Blair also issued estimates for DENTSPLY SIRONA’s Q4 2019 earnings at $0.73 EPS, Q1 2020 earnings at $0.52 EPS, Q2 2020 earnings at $0.72 EPS, Q3 2020 earnings at $0.65 EPS, Q4 2020 earnings at $0.76 EPS and FY2022 earnings at $3.30 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.10. DENTSPLY SIRONA had a positive return on equity of 8.99% and a negative net margin of 26.48%. The company had revenue of $946.20 million for the quarter, compared to the consensus estimate of $925.13 million. During the same quarter last year, the business posted $0.45 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 1.0% on a year-over-year basis.

Several other brokerages also recently commented on XRAY. ValuEngine raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. HC Wainwright reaffirmed a “neutral” rating and set a $55.00 target price (up from $49.00) on shares of DENTSPLY SIRONA in a report on Monday, May 6th. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 target price on the stock in a report on Monday, May 6th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $61.00 target price on the stock in a report on Saturday, May 11th. Finally, BidaskClub raised DENTSPLY SIRONA from a “buy” rating to a “strong-buy” rating in a report on Wednesday, May 15th. Nine analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $53.62.

XRAY traded up $0.37 during midday trading on Wednesday, hitting $53.87. 1,720,501 shares of the company were exchanged, compared to its average volume of 1,858,946. The company has a market capitalization of $12.57 billion, a PE ratio of 26.80, a PEG ratio of 2.00 and a beta of 1.11. DENTSPLY SIRONA has a 1-year low of $33.93 and a 1-year high of $55.88. The company has a current ratio of 2.06, a quick ratio of 1.35 and a debt-to-equity ratio of 0.33.

Institutional investors have recently modified their holdings of the stock. IFM Investors Pty Ltd boosted its stake in DENTSPLY SIRONA by 1.8% during the 4th quarter. IFM Investors Pty Ltd now owns 13,533 shares of the medical instruments supplier’s stock valued at $504,000 after purchasing an additional 245 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its stake in DENTSPLY SIRONA by 0.7% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 39,575 shares of the medical instruments supplier’s stock valued at $1,473,000 after purchasing an additional 268 shares during the last quarter. Advisor Partners LLC boosted its stake in DENTSPLY SIRONA by 3.1% during the 1st quarter. Advisor Partners LLC now owns 10,169 shares of the medical instruments supplier’s stock valued at $504,000 after purchasing an additional 304 shares during the last quarter. Biltmore Family Office LLC boosted its stake in DENTSPLY SIRONA by 5.8% during the 1st quarter. Biltmore Family Office LLC now owns 5,715 shares of the medical instruments supplier’s stock valued at $284,000 after purchasing an additional 315 shares during the last quarter. Finally, Private Capital Group LLC boosted its stake in DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 359 shares during the last quarter. 91.69% of the stock is owned by institutional investors and hedge funds.

In related news, insider William E. Newell sold 3,000 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $54.73, for a total value of $164,190.00. Following the completion of the sale, the insider now directly owns 28,212 shares of the company’s stock, valued at approximately $1,544,042.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Daniel P. Key bought 3,697 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was purchased at an average cost of $54.68 per share, with a total value of $202,151.96. Following the completion of the transaction, the senior vice president now directly owns 9,024 shares in the company, valued at $493,432.32. The disclosure for this purchase can be found here. Over the last three months, insiders bought 23,697 shares of company stock valued at $1,274,952 and sold 123,922 shares valued at $6,790,905. Company insiders own 0.62% of the company’s stock.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.35 annualized dividend and a dividend yield of 0.65%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 17.41%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: Options Trading – What is a Straddle?

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.